Compare IVT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IVT | PRGO |
|---|---|---|
| Founded | 2005 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | 8100 |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2005 | 2013 |
| Metric | IVT | PRGO |
|---|---|---|
| Price | $31.58 | $15.86 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $35.00 | $18.00 |
| AVG Volume (30 Days) | 635.3K | ★ 2.5M |
| Earning Date | 10-27-2026 | 11-04-2026 |
| Dividend Yield | 3.16% | ★ 7.38% |
| EPS Growth | ★ 647.37 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $299,169,000.00 | $800,000.00 |
| Revenue This Year | $12.43 | N/A |
| Revenue Next Year | $6.69 | $1.23 |
| P/E Ratio | $96.55 | ★ N/A |
| Revenue Growth | ★ 9.20 | N/A |
| 52 Week Low | $27.06 | $9.23 |
| 52 Week High | $37.22 | $16.81 |
| Indicator | IVT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 60.10 | 55.61 |
| Support Level | $30.42 | $9.84 |
| Resistance Level | $31.71 | $16.79 |
| Average True Range (ATR) | 0.69 | 0.66 |
| MACD | 0.24 | -0.10 |
| Stochastic Oscillator | 75.96 | 42.73 |
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon.com, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.